FDA permits marketing of artificial intelligence-based device to detect certain diabetes
Table of Contents
The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
Source: fda.gov
